CTMX : Insider Transactions for Cytomx Therapeutics, Inc.

Company Profile CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	47,819	75,591	103,916	162,805
Total Sell Value	$99,726	$138,068	$174,902	$267,502
Total People Sold	5	5	5	8
Total Sell Transactions	5	10	14	26
End Date	2024-02-04	2023-11-03	2023-05-05	2022-05-05

Adjust Filter Settings

Records found: 286

Page 9 of 12

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Tepper Robert I

10% Owner

– – •

2017-03-15

$0.00

D/D

(850,000)

6,820,348

Goeltz Ii Robert C.

Chief Financial Officer

• – –

2017-03-09

$4.47

$11,182

D/D

2,500

9,789

Humphrey Rachel

Chief Medical Officer

• – –

2016-12-28

$6.61

$99,994

D/D

15,117

Mccarthy Sean A.

President and CEO

• • –

2016-11-30

$9.10

$17,999

D/D

1,979

Goeltz Ii Robert C.

Chief Financial Officer

• – –

2016-11-30

$9.10

$11,723

D/D

1,289

7,289

Canaan Partners Ix Llc

Director

– • –

2016-11-30

$0.00

I/I

(400,000)

3,244,381

Shannon Timothy M

Director

– • –

2016-11-29

$11.18

$247,008

I/I

(22,086)

3,244,381

Canaan Partners Ix Llc

Director

– • –

2016-11-29

$11.18

$247,008

I/I

(22,086)

3,644,381

Canaan Partners Ix Llc

Director

– • •

2016-11-28

$11.33

$236,142

I/I

(20,840)

3,666,467

Shannon Timothy M

Director

– • –

2016-11-28

$11.33

$236,142

I/I

(20,840)

3,666,467

Canaan Partners Ix Llc

Director

– • •

2016-11-25

$11.79

$79,341

I/I

(6,729)

3,687,307

Shannon Timothy M

Director

– • –

2016-11-25

$11.79

$79,341

I/I

(6,729)

3,687,307

Canaan Partners Ix Llc

Director

– • •

2016-11-23

$11.84

$128,921

I/I

(10,890)

3,694,036

Shannon Timothy M

Director

– • –

2016-11-23

$11.84

$128,921

I/I

(10,890)

3,694,036

Shannon Timothy M

Director

– • –

2016-11-22

$11.71

$498,078

I/I

(42,550)

3,704,926

Canaan Partners Ix Llc

Director

– • •

2016-11-22

$11.71

$498,078

I/I

(42,550)

3,704,926

Shannon Timothy M

Director

– • –

2016-11-21

$11.72

$158,785

I/I

(13,548)

3,747,476

Canaan Partners Ix Llc

Director

– • •

2016-11-21

$11.72

$158,785

I/I

(13,548)

3,747,476

Shannon Timothy M

Director

– • –

2016-11-18

$11.64

$149,085

I/I

(12,805)

3,761,024

Canaan Partners Ix Llc

Director

– • •

2016-11-18

$11.64

$149,085

I/I

(12,805)

3,761,024

Shannon Timothy M

Director

– • –

2016-11-17

$11.50

$218,218

I/I

(18,971)

3,773,829

Canaan Partners Ix Llc

Director

– • •

2016-11-17

$11.50

$218,218

I/I

(18,971)

3,773,829

Shannon Timothy M

Director

– • –

2016-11-16

$11.55

$213,953

I/I

(18,517)

3,792,800

Canaan Partners Ix Llc

Director

– • •

2016-11-16

$11.55

$213,953

I/I

(18,517)

3,792,800

Shannon Timothy M

Director

– • –

2016-11-15

$11.48

$379,476

I/I

(33,064)

3,811,317

286 Records found	1 2 3 4 5 6 7 8 9 Next	Page 9 of 12

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: